日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Prognostic Landscape of TP53 Mutations in Hematologic Malignancies

TP53突变在血液系统恶性肿瘤中的预后概况

Jang, Seo Yoon; Jang, Joowon; Lee, Jee-Soo; Seong, Moon-Woo; Park, Songyi; Byun, Ja Min; Koh, Youngil; Hong, Junshik; Kim, Inho; Yoon, Sung-Soo; Shin, Dong-Yeop

Increased local DNA methylation disorder in AMLs with DNMT3A-destabilizing variants and its clinical implication

携带DNMT3A不稳定变异的急性髓系白血病中局部DNA甲基化紊乱增加及其临床意义

Lee, Dohoon; Koo, Bonil; Kim, Seokhyeon; Byun, Jamin; Hong, Junshik; Shin, Dong-Yeop; Sun, Choong-Hyun; Kim, Jaesung; Song, Ji-Joon; Jaiswal, Siddhartha; Yoon, Sung-Soo; Kim, Sun; Koh, Youngil

The role of ASXL1, SRSF2, and EZH2 mutations in chromatin dysregulation of myelodysplastic neoplasia and acute myeloid leukemia

ASXL1、SRSF2 和 EZH2 突变在骨髓增生异常综合征和急性髓系白血病染色质失调中的作用

Yu, Hosang; Hong, Junshik; Shin, Dong-Yeop; Lee, Chul-Hwan

Self-modulating therapeutic platform using engineered miRNA-responsive oligonucleotides

利用工程化miRNA响应寡核苷酸的自调节治疗平台

Ku, Doyeong; Kim, Hansol; Lim, JinA; Song, Jayeon; Yoon, Junhyeok; Jun, Liu; Min, Su-Ji; Cho, Ryeongeun; Lee, Namseok; Hur, Kyunghoon; Park, Jong-Eun; Lee, Luke P; Hong, Junshik; Kim, Yoosik; Park, Hyun Gyu

Alternative splicing patterns in genetic subtypes of diffuse large B-cell lymphoma

弥漫性大B细胞淋巴瘤基因亚型中的可变剪接模式

An, Sanyeowool; Hong, Junshik; Shin, Dong-Yeop; Byun, Ja Min; Koh, Youngil; Yoon, Sung-Soo

Azacitidine followed by R-GDP in transplant-ineligible relapsed/refractory diffuse large B-cell lymphoma: preliminary results from a multicenter, phase II study

阿扎胞苷序贯R-GDP方案治疗不适合移植的复发/难治性弥漫性大B细胞淋巴瘤:一项多中心II期研究的初步结果

Kim, Dong Hyun; Kong, Jee Hyun; Hong, Junshik; Byun, Ja Min; Shin, Dong-Yeop; Koh, Youngil; Kim, Inho; Park, Jinny; Do, Young Rok; Kim, Jeong-A; Kim, Won Seog; Shin, Ho-Jin; Yoon, Sung-Soo

Real-world experience with tisagenlecleucel for the treatment of relapsed or refractory diffuse large B-cell lymphoma in Korea

韩国使用tisagenlecleucel治疗复发或难治性弥漫性大B细胞淋巴瘤的真实世界经验

Kim, Dong Hyun; Kwon, Soyean; Cha, Seungah; Öz, Rabia Seyma; Hong, Junshik; Shin, Dong-Yeop; Koh, Youngil; Yoon, Sung-Soo; Byun, Ja Min

Selinexor plus ruxolitinib in JAK inhibitor treatment-naïve myelofibrosis: SENTRY Phase 3 study design

Selinexor联合ruxolitinib治疗JAK抑制剂初治骨髓纤维化:SENTRY 3期研究设计

Mascarenhas, John; Maher, Keri; Rampal, Raajit; Bose, Prithviraj; Podoltsev, Nikolai; Hong, Junshik; Chai, Yi; Kye, Steve; Method, Michael; Harrison, Claire

PD-1H/VISTA mediates immune evasion in acute myeloid leukemia

PD-1H/VISTA 介导急性髓系白血病的免疫逃避

Tae Kon Kim, Xue Han, Qianni Hu, Esten N Vandsemb, Carly M Fielder, Junshik Hong, Kwang Woon Kim, Emily F Mason, R Skipper Plowman, Jun Wang, Qi Wang, Jian-Ping Zhang, Ti Badri, Miguel F Sanmamed, Linghua Zheng, Tianxiang Zhang, Jude Alawa, Sang Won Lee, Amer M Zeidan, Stephanie Halene, Manoj M Pill

A Phase II Study to Evaluate the Efficacy of Bortezomib in Combination with Thalidomide in Treatment-Naïve Waldenstrom Macroglobulinemia Patients

一项评估硼替佐米联合沙利度胺治疗初治华氏巨球蛋白血症患者疗效的II期研究

Byun, Ja Min; Shin, Junghoon; Kim, Sang-A; Park, Hyunkyung; Lee, Jiyun; Shin, Dong-Yeop; Hong, Junshik; Lee, Jeong-Ok; Bang, Soo-Mee; Kim, Inho; Yoon, Sung-Soon; Koh, Youngil